Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N, Couñago F, Murcia-Mejía M, Rico-Oses M, Calvo-Crespo P, Samper P, Vallejo C, Luna J, Trueba I, Sotoca A, Cigarral C, Farré N, Manero RM, Durán X, Gispert JD, Sánchez-Benavides G, Rognoni T, Torrente M, Capellades J, Jiménez M, Cabada T, Blanco M, Alonso A, Martínez-San Millán J, Escribano J, González B, López-Guerra JL. Rodríguez de Dios N, et al. Among authors: murcia mejia m. J Clin Oncol. 2021 Oct 1;39(28):3118-3127. doi: 10.1200/JCO.21.00639. Epub 2021 Aug 11. J Clin Oncol. 2021. PMID: 34379442 Clinical Trial.
GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer.
Rodríguez De Dios N, Navarro-Martin A, Cigarral C, Chicas-Sett R, García R, Garcia V, Gonzalez JA, Gonzalo S, Murcia-Mejía M, Robaina R, Sotoca A, Vallejo C, Valtueña G, Couñago F. Rodríguez De Dios N, et al. Among authors: murcia mejia m. World J Clin Oncol. 2022 Apr 24;13(4):237-266. doi: 10.5306/wjco.v13.i4.237. World J Clin Oncol. 2022. PMID: 35582651 Free PMC article. Review.
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Couñago F, Montemuiño S, Martin M, Taboada B, Calvo-Crespo P, Samper-Ots MP, Alcántara P, Corona J, López-Guerra JL, Murcia-Mejía M, López-Mata M, Jové-Teixidó J, Chust M, Díaz-Díaz V, de Ingunza-Barón L, García-Cañibano T, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Puertas MM, Thuissard IJ, Sanz-Rosa D, de Dios NR. Couñago F, et al. Among authors: murcia mejia m. Clin Transl Oncol. 2019 Jun;21(6):735-744. doi: 10.1007/s12094-018-1976-3. Epub 2018 Nov 14. Clin Transl Oncol. 2019. PMID: 30430394
Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society).
Couñago F, Rodriguez de Dios N, Montemuiño S, Jové-Teixidó J, Martin M, Calvo-Crespo P, López-Mata M, Samper-Ots MP, López-Guerra JL, García-Cañibano T, Díaz-Díaz V, de Ingunza-Barón L, Murcia-Mejía M, Alcántara P, Corona J, Puertas MM, Chust M, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Taboada B. Couñago F, et al. Among authors: murcia mejia m. Lung Cancer. 2018 Apr;118:119-127. doi: 10.1016/j.lungcan.2018.02.008. Epub 2018 Feb 14. Lung Cancer. 2018. PMID: 29571989 Free article.
High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
Montemuiño S, Dios NR, Martín M, Taboada B, Calvo-Crespo P, Samper-Ots MP, López-Guerra JL, López-Mata M, Jové-Teixidó J, Díaz-Díaz V, Ingunza-Barón L, Murcia-Mejía M, Chust M, García-Cañibano T, Couselo ML, Puertas MM, Cerro ED, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Couñago F. Montemuiño S, et al. Among authors: murcia mejia m. Rep Pract Oncol Radiother. 2020 May-Jun;25(3):447-455. doi: 10.1016/j.rpor.2020.03.006. Epub 2020 Mar 18. Rep Pract Oncol Radiother. 2020. PMID: 32477011 Free PMC article.
Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav.
Couñago F, de Dios NR, Montemuiño S, Jové-Teixidó J, Martin M, Calvo-Crespo P, López-Mata M, Samper-Ots MP, López-Guerra JL, García-Cañibano T, Díaz-Díaz V, de Ingunza-Barón L, Murcia-Mejía M, Alcántara P, Corona J, Puertas MM, Chust M, Couselo ML, Del Cerro E, Moradiellos J, Amor S, Varela A, Thuissard IJ, Sanz-Rosa D, Taboada B. Couñago F, et al. Among authors: murcia mejia m. Lung Cancer. 2018 Sep;123:174-175. doi: 10.1016/j.lungcan.2018.06.031. Epub 2018 Jul 13. Lung Cancer. 2018. PMID: 30017426 No abstract available.
Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M, Arguís M, Díez-Presa L, Henríquez I, Murcia-Mejía M, Gascón M, Gómez D, Lafuerza A, Mur E, Azón A, Rovirosa À, Sabater S. Arenas M, et al. Among authors: murcia mejia m. Brachytherapy. 2015 Nov-Dec;14(6):859-65. doi: 10.1016/j.brachy.2015.09.001. Epub 2015 Oct 17. Brachytherapy. 2015. PMID: 26489922
Patient safety in radiation oncology in Spain: a need to change.
Pardo Masferrer J, Del Cerro Peñalver E, Contreras Martinez J, Ferrer Albiach C; Patient Safety and Quality Working Group of the Spanish Society of Radiation Oncology (SEOR). Pardo Masferrer J, et al. Clin Transl Oncol. 2020 May;22(5):751-758. doi: 10.1007/s12094-019-02184-x. Epub 2019 Jul 19. Clin Transl Oncol. 2020. PMID: 31325036 Review.